Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jeremy D. Slater, Michael Eaddy, Conor M. Butts, Inna Meltser & Sharanya Murty. (2019) The real-world economic impact of home-based video electroencephalography: the payer perspective. Journal of Medical Economics 22:10, pages 1030-1040.
Read now
Read now
Zhixiao Wang, Xuan Li, Annette Powers & Jose E Cavazos. (2015) Outcomes associated with switching from monotherapy to adjunctive therapy for patients with partial onset seizures. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 349-355.
Read now
Read now
Articles from other publishers (26)
Hind T. Hatoum, Steve Arcona, Jianbin Mao & Surrey Walton. (2023) Real‐world antiseizure medication treatment outcomes in drug‐resistant focal epilepsy patients. Epilepsia Open 8:4, pages 1556-1565.
Crossref
Crossref
Ashley Shim, Sara Radparvar, Nicole Davis, Andrew Kaplan, Kyriaki Kantaris, Amanda Devlin, John Liang & Francesco Ciummo. (2023) Evaluation of Safety Outcomes of Undiluted Levetiracetam Intravenous Push Compared to Intravenous Piggyback. Journal of Pharmacy Practice, pages 089719002311764.
Crossref
Crossref
Persefoni Ioannou, Daniella L. Foster, Josemir W. Sander, Sophie Dupont, Antonio Gil‐Nagel, Ewa Drogon O'Flaherty, Elena Alvarez‐Baron & Jasmina Medjedovic. (2022) The burden of epilepsy and unmet need in people with focal seizures. Brain and Behavior 12:9.
Crossref
Crossref
Renad Abu-Sawwa, Aaron Chase, Olubusola Fowowe & Yong Park. (2022) Effects of Epidiolex® (Cannabidiol) on seizure-related emergency department visits and hospital admissions: A retrospective cohort study. Epilepsy & Behavior 127, pages 108538.
Crossref
Crossref
Qiong Zhu, Yi Guo, Shuai Ma, Lili Yang, Zhonghua Lin, Hongbin Sun, Guangzong Li & Liang Yu. (2021) Sociodemographic factors associated with the first administration of anti-seizure medication in patients with focal epilepsy in Western China. BMC Neurology 21:1.
Crossref
Crossref
Chloe E. HillChun Chieh LinSamuel W. TermanSubhendu RathJack M. ParentLesli E. SkolarusJames F. Burke. (2021) Definitions of Drug-Resistant Epilepsy for Administrative Claims Data Research. Neurology 97:13.
Crossref
Crossref
Myrsini Gianatsi, Rebecca Bresnahan, Ruaraidh A Hill, Sarah J Nevitt, Anthony G Marson & Catrin Tudur Smith. (2021) Valproate add-on therapy for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews 2021:7.
Crossref
Crossref
François Laliberté, Mei Sheng Duh, Victoria Barghout, Guillaume Germain, Feride Frech, Craig Plauschinat, Dominique Lejeune, Manoj Malhotra & Edward Faught. (2021) Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States. Epilepsy & Behavior 118, pages 107927.
Crossref
Crossref
Allison A. Petrilla, Bryce S. Sutton, Brian I. Leinwand, Alexis Parente, Louis Ferrari & Clarence T. Wade. (2020) Incremental burden of mental health conditions in adult patients with focal seizures. Epilepsy & Behavior 112, pages 107426.
Crossref
Crossref
Charles E. Begley & Shin Jeong. 2020. Medication-Resistant Epilepsy. Medication-Resistant Epilepsy
27
33
.
. 2020. Medication-Resistant Epilepsy. Medication-Resistant Epilepsy.
Sarah N. Gibbs, Jiyoon Choi, Ibrahim Khilfeh, K. Hamzah Ahmed, Irina Yermilov & Eric Segal. (2020) The Humanistic and Economic Burden of Pediatric Focal Seizures in the United States. Journal of Child Neurology 35:8, pages 543-555.
Crossref
Crossref
Joyce A. Cramer, Tingjian Yan, Ryan Tieu, Russell L. Knoth, Contessa Fincher, Manoj Malhotra & Jiyoon Choi. (2020) Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs. Epilepsy & Behavior 102, pages 106634.
Crossref
Crossref
Jesse Fishman, Melinda Martin, David M. Labiner, Carolyn R. Lew & Barbara H. Johnson. (2019) Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States. Epilepsy & Behavior 99, pages 106331.
Crossref
Crossref
Debopam Samanta. (2019) Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. Pediatric Neurology.
Crossref
Crossref
I-Wen Pan, Sandi Lam, Dave Fitzgerald Clarke & Ya-Chen Tina Shih. (2018) Insurance transitions and healthcare utilization for children with refractory epilepsy. Epilepsy & Behavior 89, pages 48-54.
Crossref
Crossref
Komal Gupte-Singh, James P. Wilson, Jamie C. Barner, Kristin M. Richards, Karen L. Rascati & Collin Hovinga. (2018) Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid. Epilepsy & Behavior 87, pages 108-116.
Crossref
Crossref
. (2018) Drug Resistant Epilepsy and New AEDs: Two Perspectives. Epilepsy Currents 18:5, pages 304-306.
Crossref
Crossref
Halley B. Alexander, Donna K. Broshek & Mark Quigg. (2018) Quality of life in adults with epilepsy is associated with anticonvulsant polypharmacy independent of seizure status. Epilepsy & Behavior 78, pages 96-99.
Crossref
Crossref
Steve S. Chung, R. Edward Hogan, Ilan Blatt, Balduin Lawson P.Huy Nguyen, Annie M. Clark, Bob Anders & Mark B. Halvorsen. (2016) Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures. Epilepsy & Behavior 59, pages 13-20.
Crossref
Crossref
Jong Woo Lee, Javad Alam, Nichelle Llewellyn, Shelley Hurwitz, Ellen B. Bubrick, Rani A. Sarkis, Daniel Weisholtz, Hong Yu, Swapna Putta, Barbara A. Dworetzky & Page B. Pennell. (2016) Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures. Clinical Neuropharmacology 39:3, pages 128-131.
Crossref
Crossref
Yoon Sook Cho, Young-Mi Ah, Ae Hee Jung, Ki Joong Kim & Ju-Yeun Lee. (2015) Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children’s Hospital in Korea, 2001–2012. Pediatric Drugs 17:6, pages 487-496.
Crossref
Crossref
Victoria Divino, Allison A. Petrilla, Vamsi Bollu, Fulton Velez, Alan Ettinger & Charles Makin. (2015) Clinical and economic burden of breakthrough seizures. Epilepsy & Behavior 51, pages 40-47.
Crossref
Crossref
Charles E. Begley & Tracy L. Durgin. (2015) The direct cost of epilepsy in the United States: A systematic review of estimates. Epilepsia 56:9, pages 1376-1387.
Crossref
Crossref
Edward Faught, Sandra L. Helmers, Charles E. Begley, David J. Thurman, Cynthia Dilley, Chris Clark & Patty Fritz. (2015) Newer antiepileptic drug use and other factors decreasing hospital encounters. Epilepsy & Behavior 45, pages 169-175.
Crossref
Crossref
R. Edward Hogan, Ilan Blatt, Balduin Lawson, Venkatesh Nagaraddi, Toufic A. Fakhoury, Bob Anders, Annie M. Clark, Dawn Laine, Mark B. Halvorsen & Steve S. Chung. (2014) Efficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistance. Epilepsy & Behavior 41, pages 136-139.
Crossref
Crossref